Mike Royal
2014
In 2014, Mike Royal earned a total compensation of $1.2M as Former EVP, Clinical and Regulatory Affairs at Sorrento Therapeutics, a 294% increase compared to previous year.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Option Awards | $787,900 |
| Salary | $287,500 |
| Other | $32,073 |
| Total | $1,157,473 |
Royal received $787.9K in option awards, accounting for 68% of the total pay in 2014.
Royal also received $50K in bonus, $287.5K in salary and $32.1K in other compensation.
Rankings
In 2014, Mike Royal's compensation ranked 6,944th out of 13,032 executives tracked by ExecPay. In other words, Royal earned more than 46.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,944 out of 13,032 | 47th |
Division Manufacturing | 2,547 out of 4,966 | 49th |
Major group Chemicals And Allied Products | 862 out of 1,686 | 49th |
Industry group Drugs | 680 out of 1,365 | 50th |
Industry Biological Products, Except Diagnostic Substances | 127 out of 236 | 46th |
Source: SEC filing on May 13, 2016.
Royal's colleagues
We found six more compensation records of executives who worked with Mike Royal at Sorrento Therapeutics in 2014.
2014
Henry Ji
Sorrento Therapeutics
Chief Executive Officer
2014
David Miao
Sorrento Therapeutics
Former SVP, Head of ADC Development
2014
George Ng
Sorrento Therapeutics
Chief Administrative Officer
2014
George Uy
Sorrento Therapeutics
EVP and Chief Commercial Officer
2014
Richard Vincent
Sorrento Therapeutics
Chief Financial Officer
2014
Douglas Langston
Sorrento Therapeutics